MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO
March 19, 2025
MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021
August 4, 2021
Related Post
-
-
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
March 18, 2025
-
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
March 13, 2025
-
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025